Nu Skin Enterprises Inc (NUS) Gross Profit Margin starting from the third quarter 2026 to third quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Nu Skin Enterprises Inc   (NYSE: NUS)


Nu Skin Enterprises Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NUS Gross Profit Margin (Sep 30 2026)
Q3 		(Jun 30 2026)
Q2 		(Mar 31 2026)
Q1 		(Dec 31 2025)
Q4 		(Sep 30 2025)
Q3
Y / Y Revenue Change -14.49 %
Seq. Revenue Change -2.84 %
Revenue In Millions $311.01
Gross Profit Margin 65 %
Gross Profit Margin Total Ranking # 1117
Gross Profit In Millions $202.17
Y / Y Gross Profit Change -21.25 %
Seq. Gross Profit Change -7.4 %


Commenting Third Quarter 2026 Gross Profit Margin
Nu Skin Enterprises Inc experienced contraction in Gross Profit by -7.4 % to $311 millions and Revenue by -2.84 %, while Gross Profit Margin fell to 65 %, below company*s average Gross Profit Margin.


Observing third quarter 2026 results within Pharmacy Services & Retail Drugstore industry 3 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from 1050 to 1117.
Learn about Gross Margin
NUS's Gross Profit Margin third quarter 2026 Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry # 4
Retail Sector # 17
Overall # 1107

Gross Profit Margin Statistics
High Average Low
84.93 % 75.31 % 58.66 %
(Sep 30 2013)   (Sep 30 2023)


NUS Gross Income Trends • More of NUS's Profitabilty Ratios • NUS Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
NUS's Cumulative Gross Profit Margin
Pharmacy Services & Retail Drugstore Industry Gross Profit Margin Trends and Statistics
Retail Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
NUS's Gross Profit Margin Profitability versus Pharmacy Services & Retail Drugstore Industry, Retail Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for NUS's Competitors
Gross Profit Margin Profit Margin for Nu Skin Enterprises Inc 's Suppliers
Gross Profit Margin Profit Margin for NUS's Customers

You may also want to know
NUS's Annual Growth Rates NUS's Profitability Ratios NUS's Asset Turnover Ratio NUS's Dividend Growth
NUS's Roe NUS's Valuation Ratios NUS's Financial Strength Ratios NUS's Gross Profit Growth
NUS's Roa NUS's Inventory Turnover Ratio NUS's Growth Rates NUS's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2026, within Pharmacy Services & Retail Drugstore Industry Gross Profit MarginSep 30 2026 MRQ Gross ProfitSep 30 2026 MRQ Revenue
Herbalife Ltd   77.33 %$ 1,044.100  Millions$ 1,350.200  Millions
Nu Skin Enterprises Inc   65.00 %$ 202.167  Millions$ 311.009  Millions
Cvs Health Corporation  43.56 %$ 47,214.000  Millions$ 108,399.000  Millions
Petmed Express Inc   27.41 %$ 9.803  Millions$ 35.770  Millions
Guardian Pharmacy Services Inc   22.97 %$ 85.223  Millions$ 371.070  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.